News 06.04.2020 Researchers discover new member of novel drug family for ‘undruggable’ targets Findings offer a roadmap for how to build compounds to target proteins for degradation by the cell’s recycling system. Cancer Program Drug Repurposing Hub Drug Repurposing Hub Read more
News 11.02.2018 Thalidomide reveals path for targeting "undruggable" transcription factors for cancer treatment Laboratory study suggests that thalidomide-like drugs could be designed to target a broad array of transcription factors, and open a new landscape of cancer drug development. Cancer Program Cancer Read more
News 07.13.2018 Research Roundup: July 13, 2018 Clones and blood cancer, babies' microbiomes, a step toward enhancer prediction, and more. Cancer Program Cell Circuits Program Genome Regulation, Cellular Circuitry and Epigenomics Genome regulation, cell circuitry, and epigenomics Imaging Platform Klarman Cell Observatory Infectious Disease and Microbiome Program Stanley Center for Psychiatric Research Lander Lab Regev Lab ... Read more
News 10.05.2017 A new CRISPR-engineered cancer model to test therapeutics New technique for modeling human leukemia in mice may aid drug discovery, clinical trials Cancer Read more
News 06.21.2017 Aging-related mutations in blood cells represent major new risk factor for cardiovascular disease New work points to inflammation as key player in heart disease; suggests future potential for screening to reduce risk Cancer Cardiovascular disease Read more